Melatonin biological activity and binding sites in human melanoma cells
- 26 March 2003
- journal article
- Published by Wiley in Journal of Pineal Research
- Vol. 34 (4) , 242-248
Abstract
Abstract: The effects of melatonin, N‐acetylserotonin and serotonin on the growth and tyrosinase activity of SK‐Mel 23 and SK‐Mel 28 human melanoma cell lines were investigated. Binding assays were also performed to establish the nature of the binding site. SK‐Mel 28 cells were responsive to melatonin and its precursors, exhibiting a decrease in growth and an increase in tyrosinase activity after a 72 hr treatment. N‐acetylserotonin was as potent as melatonin, the minimal effective concentration (MEC, which is defined as the smallest concentration that elicits a measurable biological response, significantly different from control) being 10−8 m. Serotonin was the least potent (MEC = 10−6 m). Both melatonin antagonists, prazosin and luzindole, exhibited no effect per se and reversed both responses to melatonin. SK‐Mel 23 cells, however, showed no significant responses to the indoleamines. Competition binding assays in SK‐Mel 28 cells demonstrated the presence of binding sites to 2‐[125 I]‐iodomelatonin, which was displaced by the unlabelled hormone, by both antagonists, and by N‐acetylserotonin. The curve adjustment of the displacement values with melatonin suggests the existence of two binding sites, with the following Ki values: 1.0 × 10−10 m and 6.5 × 10−6 m. Ki values for acetylserotonin, prazosin and luzindole were, respectively, 3.8 × 10−8 m, 1.2 × 10−8 m, and 8.3 × 10−6 m. Surprisingly, in SK‐Mel 23 cells, melatonin and luzindole were able to compete with the radioligand, with Ki values of 3.1 × 10−8 and 2.4 × 10−8 m, respectively. Our data suggest that SK‐Mel 28 cells probably possess high affinity binding sites to melatonin and, in addition, MT3 low affinity binding sites, because N‐acetylserotonin was as effective as the native hormone, and prazosin effectively blocked the actions of melatonin. Both sites are functional as demonstrated by the blockade promoted by both luzindole and prazosin on the proliferative and melanogenic responses. Although growth and tyrosinase activity of SK‐Mel 23 cells were not affected by melatonin or its precursors, this cell line possesses high affinity binding sites, which may be non‐functional, or trigger responses other than the ones herein investigated.Keywords
This publication has 38 references indexed in Scilit:
- Melatonin increases p53 and p21WAFl expression in MCF-7 human breast cancer cells in vitroLife Sciences, 1999
- Pineal gland hormone melatonin binds and activates an orphan of the nuclear receptor superfamily.Journal of Biological Chemistry, 1997
- Melatonin inhibits dna synthesis in mcf-7 human breast cancer cells in vitroLife Sciences, 1996
- Orphan Nuclear Receptor RZRβ : Cyclic AMP Regulates Expression in the Pineal GlandBiochemical and Biophysical Research Communications, 1996
- Modulation of the length of the cell cycle time of MCF-7 human breast cancer cells by melatoninLife Sciences, 1996
- Stimulation of cAMP accumulation by the cloned Xenopus melatonin receptor through Gi and Gz proteinsFEBS Letters, 1995
- Melatonin interactions with cultured murine B16 melanoma cellsMelanoma Research, 1993
- Human malignant melanoma cells express high-affinity receptors for melatonin: antiproliferative effects of melatonin and 6-chloromelatoninEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Melatonin Inhibits Proliferation and Melanogenesis in Rodent Melanoma CellsExperimental Cell Research, 1993
- Melatonin binding sites are functionally coupled to phosphoinositide hydrolysis in Syrian hamster RPMI 1846 melanoma cellsLife Sciences, 1993